Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions

Area of Science:

• Cardiology
• Interventional Cardiology
• Pharmacology

Background:

• Catheter-based interventions address various congenital and acquired structural heart diseases.
• Common procedures include valve implantation/repair and septal defect closure.
• Antithrombotic therapy is essential for preventing thromboembolic events post-intervention.

Purpose of the Study:

• To review current evidence on antithrombotic strategies for structural heart interventions.
• To emphasize the need for personalized antithrombotic approaches.
• To guide healthcare professionals in managing antithrombotic therapy.

Main Methods:

• Systematic review of contemporary evidence.
• Analysis of antithrombotic therapies in transcatheter structural heart disease interventions.
• Synthesis of data considering procedural types and patient factors.

Main Results:

• Antithrombotic therapy selection varies based on intervention type and patient characteristics.
• Personalized approaches are highlighted as critical for managing risks.
• Evidence supports tailored therapy to minimize short- and long-term complications.

Conclusions:

• Individualized antithrombotic therapy is paramount for structural heart interventions.
• Healthcare professionals must stay updated on evolving guidelines.
• Personalized treatment plans improve patient outcomes and reduce complications.